Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01493555Case File
efta-efta01493555DOJ Data Set 10CorrespondenceEFTA Document EFTA01493555
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493555
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT.
For the Period 10/1/12 to 10/31/12
Note
P indicates position adjusted for Pending Trade Activity.
Unrealized Gainr Loss is shown as "N A" in cases where we do not have appropriate cost information for all tax lots comprising the position. Please contact your J P Morgan team for additional
information.
Equity Detail
Price
Quantity
Value
Adjusted Tax Cost
Unrealized
Gain./Loss
Est. Annual Inc
Yield
Original Cost
Accrued Div.
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
21.55
16,535.000
356,329.25
251,475.52
104,853.73
04033A-10-0 ARIA
BIOGEN IDEC INC
138.21
2,095.000
289,554.14
250,454.95
39,099.19
09062X-10-3 BM
DEAN FOODS CO
16.84
25,000.000
421,000.00
470,439.75
(49,439.75)
242370-10-4 DF
FACEBOOK INC-A
21.11
17,500.000
369.425.00
665,000.00
(295,575.00)
30303M-10-2 FB
Total US Large Cap Equity
$1,436,308.39
$1,637.370.22
(8201,081.83)
$0.00
0.00%
US Small/Mid Cap Equity
DEUTSCHE BK AG LDN BRH
12.81
50 000 000
640,500.00
352,529.00
287,971.00
DBL LONG ETN38
25154H-55.8 DAG
JP Morgan
Account
Page 5 of 39
Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00016432
SDNY_GM_00285630
EFTA01493555
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.